B

BridgeBio

Develops therapies for genetic diseases

Senior Manager - Transfer Pricing & Tax Analytics

Tax AccountingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree in Accounting, Finance, Tax, Economics, Data Analytics, Information Systems, or a related field is required; an advanced degree is a plus.
  • Eight or more years of progressive experience in transfer pricing, international tax, tax reporting, or tax analytics, preferably combining public accounting or consulting with in-house experience.
  • Demonstrated experience preparing or managing consolidated effective tax rate forecasts, cash-tax forecasts, tax scenario models, or comparable multi-entity tax analyses.
  • Strong understanding of U.S. corporate and international tax concepts, ASC 740 rate drivers, tax attributes, and the relationships among forecasts, provisions, tax returns, and cash payments.
  • Ability to trace data from source to conclusion and resolve inconsistencies.
  • Ability to manage recurring cycles and unplanned requests simultaneously while remaining calm and effective under pressure.
  • Ability to identify high-value automation opportunities and translate tax requirements into data specifications, workflows, validation rules, and review controls.

Responsibilities

  • Own the end-to-end operational transfer pricing calendar and implement global transfer pricing policies across decentralized research, clinical, commercial, and international activities.
  • Build and maintain legal-entity and transaction-level transfer pricing models, including segmented profit-and-loss statements, cost pools, allocation keys, markups, tested-party results, target margins, arm’s-length ranges, and variance analyses.
  • Prepare and maintain transfer pricing documentation, including functional and risk analyses, benchmarking studies, Master File and Local Files, Country-by-Country Reporting inputs, intercompany agreements, and contemporaneous support for material positions.
  • Monitor U.S. and international transfer pricing developments and lead responses to tax authority inquiries, audits, and information requests with external advisors and Legal; maintain defensible workpapers and audit-ready data trails.
  • Own recurring transfer pricing forecasts, calculations, allocations, invoices, settlements, and true-ups; reconcile results to intercompany accounts and the general ledger and coordinate timely entries with Controllership and affiliate finance teams.
  • Monitor entity profitability and intercompany results throughout the year; investigate root causes, recommend operational corrections, and execute quarter-end and year-end adjustments in coordination with Accounting, FP&A, Treasury, and affiliate finance teams.
  • Build transfer pricing forecasts by legal entity, jurisdiction, and transaction type and integrate forecasted intercompany charges, margins, settlements, and withholding taxes into consolidated effective tax rate and cash-tax projections.
  • Provide ad hoc analytics support to the broader tax team, such as book/tax difference analysis, provision reconciliations, and general ledger queries, using the data pipelines and tools built for transfer pricing forecasting.
  • Extract and reconcile information from ERP, consolidation, forecasting, and reporting systems; build controlled and repeatable calculations; and translate results into practical guidance for Tax, Accounting, FP&A, Treasury, Legal, Business Development, and executive leadership.

Desired Qualifications

  • An advanced degree is a plus.
  • Experience combining public accounting or consulting with in-house experience is preferred.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs